ArticlePharmaceutics2022

Ginsenoside Compound K Protects against Obesity through Pharmacological Targeting of Glucocorticoid Receptor to Activate Lipophagy and Lipid Metabolism.

Siwen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.